Certara, Inc. (CERT) vs Inhibrx Biosciences Inc. (INBX)
A side-by-side comparison of Certara, Inc. and Inhibrx Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CERT
Certara, Inc.
$9.50HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
INBX
Inhibrx Biosciences Inc.
$96.16HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CERT vs INBX
growth of $100 · dividends reinvested · last 6yCERT -73.6% (-19.9%/yr)INBX +159.3% (+17.2%/yr)INBX compounded faster over this window
Log scale — wide-divergence pair
CERT INBX
CERT vs INBX: by the numbers
- •CERT is the larger company ($1.48B vs $1.41B market cap).
- •Both run net losses; CERT's is the smaller (-16.75% vs -10773.46% net margin).
Metrics side by side
Valuation
| Metric | CERT | INBX |
|---|---|---|
| Forward P/E | 27.89 | N/A |
| P/S ratio | 3.62 | N/A |
| P/B ratio | 1.53 | N/A |
| EV / EBITDA | 26.85 | N/A |
| FCF yield | 4.17% | N/A |
Profitability
| Metric | CERT | INBX |
|---|---|---|
| Gross margin | 58.33% | -91.00% |
| Operating margin | 1.86% | -10386.54% |
| Net margin | -16.75% | -10773.46% |
| ROE | -7.08% | N/A |
| ROIC | 0.59% | -99.35% |
Growth (annualized)
| Metric | CERT | INBX |
|---|---|---|
| Revenue CAGR (5Y) | 9.31% | N/A |
| FCF CAGR (5Y) | 8.78% | N/A |
| Total return CAGR (5Y) | -21.31% | 27.64% |
Frequently asked
- How have CERT and INBX total returns compared?
- Over the past 5 years, CERT delivered -21.31% and INBX delivered 27.64% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Certara ROEInhibrx Biosciences ROECertara operating marginInhibrx Biosciences operating marginCertara revenue growthInhibrx Biosciences revenue growthCertara free cash flowInhibrx Biosciences free cash flow
Certara & Inhibrx Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.